Dyadic International, Inc. Share Price & Technical Analysis
DYAI · $0.66 (-5.71%)
Healthcare / Biotechnology
$0.66
-5.71%
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and…
Price chart
Seasonality
Jun has 1 positive and 3 negative years (last 5 years shown)
-12% return in Jun, -15% avg return in past 3 year Jun month.
-34% return in 2026, 19% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | -11% | 0% | 0% | 0% | -12% | – | – | – | – | – | – | -34% |
| 25 | -21% | 7% | 0% | -14% | -17% | 0% | 10% | -10% | 33% | -8% | -18% | -18% | -56% |
| 24 | -19% | 8% | 31% | -18% | 47% | -32% | -7% | -7% | -29% | 10% | 55% | 6% | 45% |
| 23 | 50% | -22% | 29% | 11% | 21% | -14% | -10% | 6% | 0% | -16% | 13% | 0% | 68% |
| 22 | -21% | 3% | -21% | -27% | 14% | 20% | -3% | -7% | -30% | 21% | -35% | -20% | -106% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$25.90M
P/E ratio
—
52W high
$1.35
52W low
$0.65
Volume
1,30,963
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Dyadic International, Inc. share price today?
- Dyadic International, Inc. (DYAI) last traded around $0.66 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does DYAI have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DYAI. Download the app for real-time alerts.
- How can I analyze Dyadic International, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.